S'identifier

Yun-Qiang Tang

Department of Hepatobiliary Surgery,
Affiliated Cancer Hospital,
Department of Hepatobiliary Surgery, Affiliated Cancer Hospital

Guangzhou Medical University

BIOGRAPHY

Yun-Qiang Tang has not added Biography.

If you are Yun-Qiang Tang and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

The complete mitochondrial genome of Japanese macaque, Macaca fuscata fuscata (Macaca, Cercopithecinae).

Mitochondrial DNA. Part A, DNA mapping, sequencing, and analysis May, 2016 | Pubmed ID: 25242185

Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients with Malignant Ascites Secondary to Unresectable Gastric Cancer.

Journal of laparoendoscopic & advanced surgical techniques. Part A Jan, 2016 | Pubmed ID: 26779722

Port-Site Metastases and Chimney Effect of B-Ultrasound-Guided and Laparoscopically-Assisted Hyperthermic Intraperitoneal Perfusion Chemotherapy.

Yonsei medical journal May, 2017 | Pubmed ID: 28332353

Optimized construction of MUC1-VNTR DNA vaccine and its anti-pancreatic cancer efficacy.

Oncology letters Apr, 2017 | Pubmed ID: 28454381

Aberrant MCT4 and GLUT1 expression is correlated with early recurrence and poor prognosis of hepatocellular carcinoma after hepatectomy.

Cancer medicine Nov, 2018 | Pubmed ID: 30306706

Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Predictor of Sorafenib Benefit in Patients with Hepatocellular Carcinoma.

Hepatology (Baltimore, Md.) Sep, 2019 | Pubmed ID: 30506570

Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.

BMC cancer Aug, 2019 | Pubmed ID: 31462277

Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients With Malignant Ascites Secondary to Unresectable Gastric Cancer.

Surgical laparoscopy, endoscopy & percutaneous techniques Feb, 2020 | Pubmed ID: 32004214

A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.

Proceedings of the National Academy of Sciences of the United States of America 03, 2020 | Pubmed ID: 32123069

Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model.

Hepatology international Jul, 2020 | Pubmed ID: 32304089

Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.

World journal of gastroenterology May, 2020 | Pubmed ID: 32476795

The tumor immune microenvironment transcriptomic subtypes of colorectal cancer for prognosis and development of precise immunotherapy.

Gastroenterology report Oct, 2020 | Pubmed ID: 33163194

Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate.

Science translational medicine 02, 2021 | Pubmed ID: 33536280

Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma.

Nature communications 12, 2021 | Pubmed ID: 34880251

INSTITUTIONS

Guangzhou Medical University

JOVE ARTICLES

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Cheng-Yang Zhang^*,1,2,

Xiao-Feng Zhang^*,3,

Jun Yuan^*,1,2,

Yuan-Feng Gong⁴,

Hui Tang⁴,

Wan-Yu Guo^1,2,

Tong-Yan Li^1,2,

Cai-Wen Li^1,2,

Yun-Qiang Tang⁴,

Ning-Fang Ma^1,2,

Ming Liu^1,2

¹, Affiliated Cancer Hospital and Institute of Guangzhou Medical University,

²Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Center for Cancer Research and Translational Medicine, School of Basic Medical Sciences, Guangzhou Medical University,

³Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University,

⁴Department of Hepatobiliary Surgery, Affiliated Cancer Hospital, Guangzhou Medical University

Cancer Research

Confidentialité

Conditions d'utilisation

Politiques

Contactez-nous

RECOMMANDER À LA BIBLIOTHÈQUE

NEWSLETTERS JoVE

Recherche

JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives

Enseignement

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Faculty Site

Auteurs

Vue d'ensemble
Processus de publication
Comité éditorial
Domaines et politique de publication
Révision par les pairs
FAQ
Soumettre

Bibliothécaires

Vue d'ensemble
Témoignages
Abonnements
Accès
Ressources
Conseil consultatif des bibliothèques
FAQ

À PROPOS DE JoVE

Vue d'ensemble
Direction
Blog
JoVE Help Center

Yun-Qiang Tang

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Hepatobiliary Surgery,Affiliated Cancer Hospital,Department of Hepatobiliary Surgery, Affiliated Cancer Hospital

Guangzhou Medical University

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Department of Hepatobiliary Surgery,
Affiliated Cancer Hospital,
Department of Hepatobiliary Surgery, Affiliated Cancer Hospital